These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Functional characterization of human oncoprotein gankyrin in Zebrafish. Kim SY; Hur W; Choi JE; Kim D; Wang JS; Yoon HY; Piao LS; Yoon SK Exp Mol Med; 2009 Jan; 41(1):8-16. PubMed ID: 19287195 [TBL] [Abstract][Full Text] [Related]
6. Structure of the oncoprotein gankyrin in complex with S6 ATPase of the 26S proteasome. Nakamura Y; Nakano K; Umehara T; Kimura M; Hayashizaki Y; Tanaka A; Horikoshi M; Padmanabhan B; Yokoyama S Structure; 2007 Feb; 15(2):179-89. PubMed ID: 17292836 [TBL] [Abstract][Full Text] [Related]
7. The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation. Higashitsuji H; Liu Y; Mayer RJ; Fujita J Cell Cycle; 2005 Oct; 4(10):1335-7. PubMed ID: 16177571 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53. Kuo TC; Chang PY; Huang SF; Chou CK; Chao CC Biochem Pharmacol; 2012 Mar; 83(6):758-68. PubMed ID: 22230478 [TBL] [Abstract][Full Text] [Related]
9. Discovery of a small-molecule binder of the oncoprotein gankyrin that modulates gankyrin activity in the cell. Chattopadhyay A; O'Connor CJ; Zhang F; Galvagnion C; Galloway WR; Tan YS; Stokes JE; Rahman T; Verma C; Spring DR; Itzhaki LS Sci Rep; 2016 Apr; 6():23732. PubMed ID: 27046077 [TBL] [Abstract][Full Text] [Related]
10. Gankyrin, the 26 S proteasome, the cell cycle and cancer. Mayer RJ; Fujita J Biochem Soc Trans; 2006 Nov; 34(Pt 5):746-8. PubMed ID: 17052188 [TBL] [Abstract][Full Text] [Related]
11. Gankyrin: a new oncoprotein and regulator of pRb and p53. Dawson S; Higashitsuji H; Wilkinson AJ; Fujita J; Mayer RJ Trends Cell Biol; 2006 May; 16(5):229-33. PubMed ID: 16581249 [TBL] [Abstract][Full Text] [Related]
12. Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6 ATPase of the 26 S proteasome. Dawson S; Apcher S; Mee M; Higashitsuji H; Baker R; Uhle S; Dubiel W; Fujita J; Mayer RJ J Biol Chem; 2002 Mar; 277(13):10893-902. PubMed ID: 11779854 [TBL] [Abstract][Full Text] [Related]
13. The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53. Krzywda S; Brzozowski AM; Higashitsuji H; Fujita J; Welchman R; Dawson S; Mayer RJ; Wilkinson AJ J Biol Chem; 2004 Jan; 279(2):1541-5. PubMed ID: 14573599 [TBL] [Abstract][Full Text] [Related]
14. Discovery of multiple interacting partners of gankyrin, a proteasomal chaperone and an oncoprotein--evidence for a common hot spot site at the interface and its functional relevance. Nanaware PP; Ramteke MP; Somavarapu AK; Venkatraman P Proteins; 2014 Jul; 82(7):1283-300. PubMed ID: 24338975 [TBL] [Abstract][Full Text] [Related]
15. Gankyrin: an intriguing name for a novel regulator of p53 and RB. Lozano G; Zambetti GP Cancer Cell; 2005 Jul; 8(1):3-4. PubMed ID: 16023592 [TBL] [Abstract][Full Text] [Related]
16. Evidence that proteasome-dependent degradation of the retinoblastoma protein in cells lacking A-type lamins occurs independently of gankyrin and MDM2. Nitta RT; Smith CL; Kennedy BK PLoS One; 2007 Sep; 2(9):e963. PubMed ID: 17896003 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the binding interaction between the oncoprotein gankyrin and a grafted S6 ATPase. Chapman AM; Rogers BE; McNaughton BR Biochemistry; 2014 Nov; 53(44):6857-9. PubMed ID: 25343477 [TBL] [Abstract][Full Text] [Related]
18. The oncoprotein gankyrin interacts with RelA and suppresses NF-kappaB activity. Higashitsuji H; Higashitsuji H; Liu Y; Masuda T; Fujita T; Abdel-Aziz HI; Kongkham S; Dawson S; John Mayer R; Itoh Y; Sakurai T; Itoh K; Fujita J Biochem Biophys Res Commun; 2007 Nov; 363(3):879-84. PubMed ID: 17904523 [TBL] [Abstract][Full Text] [Related]
19. The overexpression of multidrug resistance-associated proteins and gankyrin contribute to arsenic trioxide resistance in liver and gastric cancer cells. Chen X; Zhang M; Liu LX Oncol Rep; 2009 Jul; 22(1):73-80. PubMed ID: 19513507 [TBL] [Abstract][Full Text] [Related]